Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

OBJECTIVE: We prospectively recorded clinical and laboratory parameters from patients with metastatic non-small cell lung cancer (NSCLC) treated with 2nd line PD-1/PD-L1 inhibitors in order to address their effect on treatment outcomes. MATERIALS AND METHODS: Clinicopathological information (age, pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Rounis, Konstantinos, Makrakis, Dimitrios, Papadaki, Chara, Monastirioti, Alexia, Vamvakas, Lambros, Kalbakis, Konstantinos, Gourlia, Krystallia, Xanthopoulos, Iordanis, Tsamardinos, Ioannis, Mavroudis, Dimitrios, Agelaki, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168865/
https://www.ncbi.nlm.nih.gov/pubmed/34061904
http://dx.doi.org/10.1371/journal.pone.0252537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168865/
https://www.ncbi.nlm.nih.gov/pubmed/34061904
http://dx.doi.org/10.1371/journal.pone.0252537

Ejemplares similares